- Nachrichtendetail
-
28.05.2024 13:41:17 - dpa-AFX: *JOHNSON & JOHNSON TO ACQUIRE CLINICAL-STAGE BISPECIFIC FOR ATOPIC DERMATITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Johnson & Johnson | 853260 | NYSE | 145,650 | 18.06.24 03:00:07 | -0,300 | -0,21% | 145,650 | 145,750 | 145,960 | 145,650 |
